Category: News

June 22, 2022

One of these – dubbed V116 – is a cocktail of 21 Streptococcus pneumoniae serotypes designed to have the most benefit in adult populations, and it has just cleared a phase 1/2 trial as it embarks on a phase 3 […]

June 20, 2022

The deal gives Valneva a cash injection that it will be able to use to advance Lyme disease candidate VLA15 towards the market, but the revised licensing terms means that the French biotech will shoulder more of the financial cost […]

June 2, 2022

The most immediate effect of the deal is a much-needed infusion of funds for Repare, which went public in 2020 at a price of $20 a share. The company’s stock soared above $42 in early 2021, only to plummet as […]

June 1, 2022

Until the launch of GSK’s Benlysta in 2011, people with lupus didn’t have a treatment option that targeted the disease’s underlying cause, relying instead on steroids and immunosuppressants to keep symptoms under control. AstraZeneca’s Saphnelo followed Benlysta to market in […]

May 26, 2022

U.S. officials have arrested Enochian BioSciences co-founder Serhat Gümrükcü. The researcher is charged with conspiring to use interstate commerce facilities in the commission of murder-for-hire which resulted in a death. Enochian is developing gene-modified cellular and immune therapies for infectious […]

May 19, 2022

Patel announced in a LinkedIn post he is leaving the FDA after more than a decade to join Google. In his new role, Patel said he will help Google build a digital health and regulatory strategy. “The power of technology, […]

May 12, 2022

After two FDA rejections against China-made cancer immunotherapies this year, another Chinese pharma hopes it has the data to crack the agency’s doors open. But one major uncertainty remains. Thursday, Jiangsu Hengrui Medicine said a global phase 3 trial of […]

May 12, 2022

Taiwan-based contract development and manufacturing organization (CDMO) Bora Pharmaceuticals recently announced the establishment of Bora Biologics Co., Ltd., to focus on the development of bio-pharmaceuticals. Bora Biologics has investors Taishin Healthcare Limited Partnership and Dr. Allen Chao, founder of Tanvex […]

April 8, 2022

Legend Biotech’s founding chief scientific officer has left the company without a new destination. Takeda has signed another gene therapy deal with Evozyne to work on protein sequences. Pfizer is rolling out a voluntary retirement scheme in India amid a […]

April 7, 2022

RSV is one of the most common, and confounding, viruses that cause infections in humans. There’s no approved vaccine and current treatment options focus on managing symptoms, much like a cold. For most people who contract RSV, that’s enough; they […]

April 7, 2022

After safety concerns derailed an approval of Akebia Therapeutics’ blockbuster hopeful vadadustat late last month, the company warned that a restructuring was in the cards. This week, Akebia telegraphed job cuts for nearly half of its workforce and revealed deeper […]

March 28, 2022

Researchers at the New York Stem Cell Foundation Research Institute have unveiled a new platform for discovering cellular signatures of disease, which integrates robotic systems for studying patient cells with artificial intelligence methods for image analysis. Using their automated cell […]